6 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for Clover Health Investments in the last year. There are currently 1 sell rating, 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should “hold” CLOV shares.
Is Clover Health a buy now?
CLOV is now down 76% from its 52-week high of $11.13. At this price, CLOV is a buy based on its QoQ revenue and membership growth. For long-term investors it offers additional value based on the healthcare technology landscape.
Is Clover a buy or sell?
USD 1.46 0.03 2.10%
Given the investment horizon of 90 days and your highly speculative risk level, our recommendation regarding Clover Health Investments is ‘Sell‘.
Is Clover Health Investments a good buy?
Clover Health Investments, Corp.
may be overvalued. Its Value Score of F indicates it would be a bad pick for value investors. The financial health and growth prospects of CLOV, demonstrate its potential to underperform the market.
Is Clover health investments gonna grow?
For full-year 2022, Clover Health is reaffirming its previously provided guidance and commentary: Insurance membership is expected to average 84,000 – 85,000, a growth rate of 26% – 27% as compared to the 2021 average.
Why is clover stock dropping?
But Hindenburg Research published a report that claimed Clover and Palihapitiya had misled investors by not disclosing that the Department of Justice had been investigating its business model. Following the damning report, CLOV plunged 50% by the end of May 2021.
Is CLOV a hold?
(NASDAQ:CLOV) Given Average Recommendation of “Hold” by Analysts – MarketBeat.
Is Clov undervalued?
Clover Health Investments shows a prevailing Real Value of $2.55 per share. The current price of the firm is $1.44. Based on Macroaxis valuation methodology, the firm appears to be undervalued.
0.0835.
| Low | Next Value | High |
|---|---|---|
| 0.02983 | 1.49 | 6.32 |
What is going on with clover health?
Clover Health posted a $48.4 million loss in the first quarter of 2021, nearly doubling its year-over-year losses as medical costs jumped under the pandemic. The startup insurer reported a $28.2 million loss in the first quarter of 2020, according to the company’s earnings report released this week.
Why is Clov stock up?
The Promising SPAC Which Turned Into A Penny Stock
Clover went public with a $7 billion valuation in January 2021 through a SPAC deal and was hyped up due to its connection to the “King of SPACs,” billionaire venture capitalist investor Chamath Palihapitiya.
How high can Clover Health stock go?
Stock Price Forecast
The 6 analysts offering 12-month price forecasts for Clover Health Investments Corp have a median target of 3.00, with a high estimate of 7.00 and a low estimate of 2.00. The median estimate represents a +91.08% increase from the last price of 1.57.
Why is Clover Health stock so low?
Clover posted a loss on the basis of adjusted earnings before interest, taxes, depreciation, and amortization (Ebitda) of $87.5 million, compared with a $107.1 million loss on the metric a year before. Analysts tracked by FactSet were modeling an $80.1 million adjusted Ebitda loss.
Is CLOV stock a meme stock?
CLOV was not only a SPAC stock, but 100% a battleground meme stock. And for the vast majority of those companies, there has been a huge price to play with that inclusion.
Does Clover Health have debt?
Clover Health Investments long term debt from 2020 to 2022. Long term debt can be defined as the sum of all long term debt fields. Clover Health Investments Corp. is a healthcare technology company.
Compare CLOV With Other Stocks.
| Stock Name | Zepp Health (ZEPP) |
|---|---|
| Country | China |
| Market Cap | $0.085B |
| PE Ratio | 0.00 |
Where is Clov stock headed?
CLOV Stock Price Prediction
Based on 3 Wall Street analysts offering 12 month price targets for Clover Health Investments in the last 3 months. The average price target is $3.17 with a high forecast of $3.50 and a low forecast of $3.00. The average price target represents a 52.77% change from the last price of $2.08.
How much cash does clover have?
Compare CLOV With Other Stocks
| Clover Health Investments Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2021 | $615 |
| 2020 | $97 |
| 2019 | $ |
How does Clover Health make money?
How Does Clover Health Make Money? While Clover could dabble in commercial insurance in the future, the company’s revenue is almost entirely derived from government-sponsored payments. Clover also makes commissions from reinsurance agreements (less than 1% of revenue in FY20).
What kind of stock is CLOV?
Class A Common Stock (CLOV)
How long has Clover Health been in business?
The company was founded in 2014 by Kris Gale and Vivek Garipalli, and currently operates in New Jersey.In September 2015, Clover Health raised $100 million in equity and debt funding, led by First Round Capital.
What institutions own Clover health?
Largest shareholders include Vanguard Group Inc, BlackRock Inc., VTSMX – Vanguard Total Stock Market Index Fund Investor Shares, NAESX – Vanguard Small-Cap Index Fund Investor Shares, IWM – iShares Russell 2000 ETF, State Street Corp, Pnc Financial Services Group, Inc., Geode Capital Management, Llc, VISGX – Vanguard
Is Clov in an ETF?
Clover Health Investments Corp. Class A is a company in the U.S. stock market and it is a holding in 39 U.S.-traded ETFs. CLOV has around 26.9M shares in the U.S. ETF market. The largest ETF holder of CLOV is the iShares Russell 2000 ETF (IWM), with approximately 8.57M shares.